Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (CYCC)

CUSIP: 23254L801

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 5 signals
Share change
+93,921
SEC-reported price per share
$2.67
Number of holders
13
Value change
+$249,543
Number of buys
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,584,707

Security key

23254L801

Report period

Q4 2023

Institutions

13

Top holders

10

Ownership snapshot

Top reported holders of CYCC - Cyclacel Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Spiro George Rombotis
Disclosed value leader
Spiro George Rombotis
Comparable rows
0/15
Latest evidence
21 Dec 2023
3/4/5 13F Highest disclosed value: $227,601 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Spiro George Rombotis has the largest disclosed position value at $227.6K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Spiro George Rombotis's linked filing trail.
Disclosed position value Top 5
Spiro George Rombotis $227.6K
Kenneth M. Ferguson $149K
Karin L. Walker $134.6K
Sam L. Barker $134K
Christopher S. Henney $130.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Spiro George Rombotis
3/4/5
President and CEO, Director
mixed-class rows
$227,601
184,728 shares
mixed-class rows
21 Dec 2023
Kenneth M. Ferguson
3/4/5
Director
mixed-class rows
$149,016
87,390 shares
mixed-class rows
30 Jun 2023
Karin L. Walker
3/4/5
Director
mixed-class rows
$134,596
83,040 shares
mixed-class rows
30 Jun 2023
Sam L. Barker
3/4/5
Director
mixed-class rows
$133,976
82,853 shares
mixed-class rows
30 Jun 2023
Christopher S. Henney
3/4/5
Director
mixed-class rows
$130,661
81,853 shares
mixed-class rows
30 Jun 2023
Robert J. Spiegel
3/4/5
Director
mixed-class rows
$130,661
81,853 shares
mixed-class rows
30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
13
Shares
93,921
Rows available
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
0
Q4 2023 holders
13
Holder diff
13
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .